ADRB2 and prostate cancer: Given the fact that, in mice with prostate cancer, b2-AR activation by stress induces MDSCs accumulation on tumor site, is reasonable to hypothesize that the immunosuppressive functions of such metabolic pathways in prostate cancer are correlated with MDSCs.